Target intelligence / Profile preview

Tumor protein D52–mitochondrial ribosomal protein S28 readthrough (TPD52-MRPS28 readthrough)

Target
TPD52-MRPS28 readthrough
Molecular classification
Other (readthrough fusion protein; not a known member of any classic therapeutic target family)
01

Overview

TPD52-MRPS28 readthrough (ENSG00000276418) refers to a predicted transcript that results from transcriptional readthrough between the TPD52 and MRPS28 genes. Such readthrough proteins are generally bioinformatically annotated, with no evidence for stable protein product, biological function, or therapeutic relevance. TPD52 encodes a cytoplasmic protein involved in vesicle trafficking and cell proliferation, and is implicated in several cancers[3][1]. MRPS28 encodes a mitochondrial ribosomal protein that is part of the 28S subunit, necessary for mitochondrial translation[2]. There is currently no experimental evidence that the readthrough transcript is expressed as a functional protein, nor that it plays any therapeutic, diagnostic, or biological role. Therefore, this entity should not be considered a validated target for research or drug discovery.

Other names
TPD52-MRPS28 readthroughENSG00000276418

Beyond the preview

Go deeper on Tumor protein D52–mitochondrial ribosomal protein S28 readthrough (TPD52-MRPS28 readthrough).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tumor protein D52–mitochondrial ribosomal protein S28 readthrough (TPD52-MRPS28 readthrough).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call